Literature DB >> 312324

The effect of aprotinin on luteolytic and uterine contractile mechanisms in the pregnant rat at term.

E T Whalley, A J Riley.   

Abstract

The effect of the kallikrein inhibitor aprotinin on luteal function, uterine activity and parturition was studied in primigravid pregnant rats. Luteal function was monitored by the determination of serum progesterone levels. Aprotinin given daily from Day 19 to Day 22 of gestation had no effect on progesterone concentrations compared to saline-treated controls, but indomethacin delayed the decline in progesterone levels over the same time period. Aprotinin treatment had no effect on fetal and placental weights from Days 19 to 22 of gestation. Aprotinin infusion in Day-22 pregnant rats resulted in a reduction in uterine motility (studied by continuous recording in conscious rats by means of an intrauterine microballoon) in 10/12 rats. Continuous infusion of aprotinin into rats which had been allowed to deliver one young resulted in a significantly prolonged duration of parturition compared to that in saline-infused controls. In one rat the delivery process was completely arrested and recommended only when the infusion was stopped. Aprotonin had no effect on either the spontaneous or oxytocin-induced uterine contractions of the isolated Day-22 pregnant rat uterus. It is concluded that the kallikrein-kinin system in the late pregnant rat does not appear to be involved in the luteolytic process but may play a functional role in the control of uterine and/or cervical function before and during parturition.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 312324     DOI: 10.1530/jrf.0.0550377

Source DB:  PubMed          Journal:  J Reprod Fertil        ISSN: 0022-4251


  3 in total

1.  Proceedings of the British Pharmacological Society. 17th-19th December, 1979: University of London (Institute of Education).

Authors: 
Journal:  Br J Pharmacol       Date:  1980-06       Impact factor: 8.739

2.  Mechanism of trypsin-induced contraction in the rat myometrium: the possible involvement of a novel member of protease-activated receptor.

Authors:  Y Shintani; K Hirano; T Nakayama; J Nishimura; H Nakano; H Kanaide
Journal:  Br J Pharmacol       Date:  2001-08       Impact factor: 8.739

3.  Kallikrein-induced uterine contraction independent of kinin formation.

Authors:  J Chao; J Buse; K Shimamoto; H S Margolius
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.